Antibiotic resistance: Lessons for the future

Clinical Infectious Diseases

Volumn 27, Issue SUPPL.1, 1998, Pages

  Moellering Jr , Robert C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CONFERENCE PAPER; DRUG USE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 17344373043     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514902     Document Type: Conference Paper

References (16)

1. ASM Task Force on Antibiotic Resistance. 1995. Report of the ASM Task Force on Antibiotic Resistance. Antimicrob Agents Chemother 1995;39(suppl):2-23.
2. Noble WC, Virani Z, Cree RGA. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis 12201 to Staphylococcus aureits. FEMS Microbiol Lett 1992;93:195-8.
3. Centers for Disease Control and Prevention. Diphtheria epidemic - new independent states of the former Soviet Union, 1990-1994. MMWR Morb Mortal Wkly Rep 1995;44:177-81.
4. Moellering RC Jr. Interaction between antimicrobial consumption and selection of resistant bacterial strains. Scand J Infect Dis 1990;(suppl 70):18-24.
5. Levy SB, Burke JP, Wallace CK. Epilogue. Rev Infect Dis 1987;9:S313-6.
6. Klare I, Heier H, Claus H, Reissbrodt R, Witte W. VanA-mediated high level glycopeptide resistance in 'Enterococcus faecium from animal husbandry. FEMS Microbiol Lett 1995;125:165-72.
7. Pérez-Trallero E, Zigorraga C. Resistance to antimicrobial agents as a public health problem: importance of the use of antibiotics in animals. International Journal of Antimicrobial Agents 1995;6:59-63.
8. Doucet-Populaire F, Trieu-Cuot P, Dosbaa I, Andremont A, Courvalin P. Inducible transfer of conjugative transposon Tn1545 from Enterococcus faecalis to Listeria monocytogenes in the digestive tracts of gnotobiotic mice. Antimicrob Agents Chemother 1991;35:185-7.
9. Moellering RC Jr. The use and abuse of antibiotic combinations. Rhode Island Medical Journal 1972;55:341-60.
10. Milatovic D, Braveny I. Development of resistance during antibiotic therapy. Eur J Clin Microbiol 1987;6:234-44.
11. Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR. Antibiotic therapy for Pseudomonas aeniginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 1989;87:540-6.
12. Nichols L, Maki DG. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeniginosa lower respiratory tract infections: is combination therapy the solution? Chemioterapia 1985;4:102-9.
13. Bodey GP, Jadeja L, Elting L. Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch Intern Med 1985;145:1621-9.
14. Billstein SA. How the pharmaceutical industry brings an antibiotic drug to market in the United States. Antimicrob Agents Chemother 1994;38:2679-82.
15. Moellering RC Jr. Past, present and future of antimicrobial agents. Am J Med 1995;99(suppl 6A):11S-8.
16. Aumercier M, Bouhallab S, Capmau M-L, LeGoffic F. RP59500: a proposed mechanism for its antibactericidal activity. J Antimicrob Chemother 1992;30(suppl A):9-14.